Human infections due to streptococcus dysgalactiae subspedes equisimilis

Clinical Infectious Diseases

Volumn 49, Issue 5, 2009, Pages 766-772

  Brandt, Claudia M ^a   Spellerberg, Barbara ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AMINOGLYCOSIDE; BACTERIAL TOXIN; BETA LACTAM; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

BACTERIAL GENE; BACTERIAL STRAIN; GENE SEQUENCE; GENE TRANSFER; GENETIC ASSOCIATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS INFECTION; VIRULENCE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; HUMANS; PHYLOGENY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VIRULENCE;

EID: 70149091079     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605085     Document Type: Review

References (79)

1. VandammeP,PotB,FalsenE,KerstersK,DevrieseLA. TaxonomicstudyofLancefieldstreptococcalgroupsC,G,andL(Streptococcusdysgalactiae) andproposalofS.dysgalactiaesubsequisimilissubsnov.IntJSystBacteriod1996;46: 774-781(Pubitemid26231298)
2. Vieira V, Teixeira L, Zahner V, et al. Genetic relationships among the different phenotypes of Streptococcus dysgalactiae strains. Int J Syst Bacteriol 1998; 48:1231-1243
3. EfstratiouA.PyogenicstreptococciofLancefieldgroupsCandGaspathogensinman. SocApplBacteriolSympSer1997;26:72S-9S.(Pubitemid127757899)
4. Gaunt PN, Seal DV. Group G streptococcal infections. J Infect 1987; 15:5-20.
5. Broyles LN, Van Beneden C, Beall B, et al. Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009; 48:706-712
6. Gerber MA, Randolph MF, Martin NJ, et al. Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics 1991; 87:598-603.
7. StrykerWS,FraserDW,FacklamRR. FoodborneoutbreakofgroupGstreptococcalpharyngitis.AmJEpidemiol1982;116: 533-540(Pubitemid12032613)
8. EfstratiouA. OutbreaksofhumaninfectioncausedbypyogenicstreptococciofLancefieldgroupsCandG. JMedMicrobiol1989;29:207-219(Pubitemid19188080)
9. TurnerJC,HaydenFG,LoboMC,RamirezCE,Murren.D. EpidemiologicevidenceforLancefieldgroupCbeta- hemolyticstreptococciasacauseofexudativepharyngitisincollegestudents. JClinMicrobiol1997;35:1-1(Pubitemid26422619)
10. Cimolai N, Morrison BJ, MacCulloch L, Smith DF, Hlady J. Beta-haemolytic non-group A streptococci and pharyngitis: a case-control study. Eur J Pediatr 1991; 150:776-779
11. Chowdhury MNH, Kambal AM, Al-Eissa YA, et al. Non-group A streptococci: are they pathogens in the throat? J R Soc Health 1997; 117:160-163
12. Zaoutis T, Attia M, Gross R, Klein J. The role of group C and group G streptococci in acute pharyngitis in children. Clin Microbiol Infect 2004; 10:37-40. (Pubitemid 38128590)
13. HaidanA,TalaySR,RohdeM,etal. PharyngealcarriageofgroupCandgroupGstreptococciandacuterheumaticfeverinanabori ginalpopulation.Lancet2000;356:1167-1169(Pubitemid30769390)
14. ReidHF,BassettDC,Poon-KingT,ZabriskieJB,ReadSE. GroupGstreptococciinhealthyschool- childrenandinpatientswithglomerulonephritisinTrinidad.JHyg(Lond)1985;94: 61-68(Pubitemid15160428)
15. Rider MA, McGregor JC. Group G streptococcus-an emerging cause of graft loss? Br J Plast Surg 1994; 47:346-348
16. Auckenthaler R, Hermans PE, Washington. JA 2nd. Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 1983; 5:196-204.
17. BarnhamMR,WeightmanNC. ChangingincidenceofdetectedstreptococcalbacteraemiainNorthYorkshire,England. IndianJMedRes2004;119(Suppl):160-163(Pubitemid39004469)
18. Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to beta-hemolytic streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 2002; 112: 622-626 (Pubitemid 34597162)
19. Davies MR, McMillan DJ, Beiko RG, et al. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 2007; 44: 1442-1454
20. Cohen-Poradosu R, Jaffe J, Lavi D, et al. Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis 2004; 10:1455-1460
21. Armstrong D, Blevins A, Louria DB, et al. Groups B, C, and G streptococcal infections in a cancer hospital. Ann N Y Acad Sci 1970; 174: 511-522
22. CarstensenH,PersC,PrydsO.GroupGstreptococcalneonatalsepticaemia: twocasereportsandabriefreviewofliterature.ScandJInfectDis1988;20: 407-410(Pubitemid18221776)
23. Lee PC, Wetherall BL. Cross-reaction between Streptococcus pneumoniae and group C streptococcal latex reagent. J Clin Microbiol 1987; 25:152-153
24. Galperine T, Cazorla C, Blanchard E, et al. Streptococcus canis infections in humans: retrospective study of 54 patients. J Infect 2007; 55:23-26
25. Vandamme P, Devriese LA, Haesebrouck F, Kersters K. Streptococcus intestinalis Robinson et al. 1988 and Streptococcus alactolyticus Farrow et al. 1984 are phenotypically indistinguishable. Int J Syst Bacteriol 1999; 49:737-741
26. Brandt CM, Haase G, Schnitzler N, Zbinden R, Lutticken R. Characterization of blood culture isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen. J Clin Microbiol 1999; 37:4194-4197
27. Tanaka D, Isobe J, Watahiki M, et al. Genetic features of clinical isolates of Streptococcus dysgalactiae subsp. equisimilis possessing Lancefield's group A antigen. J Clin Microbiol 2008; 46:1526-1529
28. EfstratiouA,ColmanG,HahnG,etal. BiochemicaldifferencesamonghumanandanimalstreptococciofLancefieldgroupCorgroupG. JMedMicrobiol1994;41:145-148(Pubitemid24257283)
29. Woo PC, Fung AM, Lau SK, Wong SS, Yuen KY. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001; 39:3147-3155
30. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002; 15:613-630 (Pubitemid 41184081)
31. Kawata K, Minakami T, Mori Y, et al. rDNA sequence analyses of Streptococcus dysgalactiae subsp. equisimilis isolates from pigs. Int J Syst Evol Microbiol 2003; 53:1941-1946
32. Hassan AA, Khan IU, Abdulmawjood A, Lammler C. Inter- and intraspecies variations of the 16S-23S rDNA intergenic spacer region of various streptococcal species. Syst Appl Microbiol 2003; 26:97-103. (Pubitemid 36514250)
33. PoyartC,QuesneG,CoulonS,BercheP,Trieu-CuotP.Identificationofstreptococci- specieslevelbysequencingthegeneencodingthemanganese- dependentsuperoxidedismutase.JClinMicrobiol1998;36:41-47(Pubitemid28047430)
34. Franken C, Haase G, Brandt C, et al. Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb. Mol Microbiol 2001; 41:925-935 (Pubitemid 34209000)
35. Ikebe T, Murayama S, Saitoh K, et al. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan. Epidemiol Infect 2004; 132:145-149 (Pubitemid 38240083)
36. Lindgren PE, Signas C, Rantamaki L, Lindberg M. A fibronectin-binding protein from Streptococcus equisimilis: characterization of the gene and identification of the binding domain. Vet Microbiol 1994; 41:235-247
37. KlineJB,XuS,BisnoAL,CollinsCM. Identificationofafibronectinbindingprotein(GfbA)inpathogenicgroupGstreptococci. InfectImmun1996;64:2122-2129(Pubitemid26165675)
38. Ullberg M, Karlsson I, Wiman B, Kronvall G. Two types of receptors for human plasminogen on group G streptococci. APMIS 1992; 100:21-28
39. Gase K, Gase A, Schirmer H, Malke H. Cloning, sequencing and functional overexpression of the Streptococcus equisimilis H46A gapC gene encoding a glyceraldehyde-3-phosphate dehydrogenase that also functions as a plasmin(ogen)-binding protein: purification and biochemical characterization of the protein. Eur J Biochem 1996; 239:42-51.
40. Pancholi V, Fischetti VA.α-Enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 1998; 273:14503-14515 (Pubitemid 28319172)
41. Chhatwal GS, Preissner KT, Muller-Berghaus G, Blobel H. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli. Infect. Immun 1987; 55:1878-1883.
42. Valentin-WeigandP,Grulich-HennJ,ChhatwalGS,etal. Mediationofadherenceofstreptococci- humanendothelialcellsbycomplementSprotein(vitronectin).InfectImmun1988;56: 2851-2855(Pubitemid18259938)
43. Spellerberg B, Rozdzinski E, Martin S, et al. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun 1999; 67:871-878
44. OkumuraK,HaraA,TanakaT,etal. CloningandsequencingthestreptolysinOgenesofgroupCandgroupGstreptococci. DNASeq1994;4:325-328(Pubitemid2137588)
45. Nizet V, Beall B, Bast DJ, et al. Genetic locus for streptolysin S production by group A. streptococcus. Infect Immun 2000; 68:4245-4254 (Pubitemid 30434580)
46. Stevens DL. Invasive streptococcal infections. J Infect Chemother 2001; 7:69-80.
47. Musser JM, Kapur V, Szeto J, et al. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1. protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003.
48. Banks DJ, Beres SB, Musser JM. The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 2002; 10:515-521
49. Kalia A, Bessen DE. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol Lett 2003; 219:291-295 (Pubitemid 36302611)
50. Igwe EI, Shewmaker PL, Facklam RR, et al. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 2003; 229:259-264
51. Corson AP, Garagusi VF, Chretien JH. Group C beta-hemolytic streptococci causing pharyngitis and scarlet fever. South Med J 1989; 82: 1119-1121
52. dys). FEMS Immunol Med Microbiol 2002; 34:159-167
53. dys-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections. Int J Med Microbiol 2005; 295:539-546
54. Miyoshi-Akiyama T, Zhao J, Kato H, et al. Streptococcus dysgalactiaederived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol 2003; 47:1589-1599
55. Heng NC, Ragland NL, Swe PM, et al. Dysgalacticin: a novel, plasmidencoded antimicrobial protein (bacteriocin) produced by Streptococcus dysgalactiae subsp. equisimilis. Microbiology 2006; 152:1991-2001.
56. FischettiVA.StreptococcalMprotein:moleculardesignandbiologicalbehavior. ClinMicrobiolRev1989;2:285-314.(Pubitemid19181596)
57. Centers for Disease Control and Prevention. Streptococcus pyogenes emm sequence database. Blast-emm. Available at: http://www.cdc.gov/ ncidod/biotech/strep/strepblast.htm. Accessed 15 July 2009.
58. EfstratiouA.Theserotypingofhospitalstrainsofstreptococcibelonging- LancefieldgroupCandgroupG.JHyg(Lond)1983;90:71-80.(Pubitemid13162469)
59. Leyer A, Schmidt KH. Genetic organisation of the M protein region in human isolates of group C and G streptococci: two types of multigene regulator-like (mgrC) regions. Mol Gen Genet 2000; 262:965-976
60. Schnitzler N, Podbielski A, Baumgarten G, Mignon M, Kaufhold A. M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol 1995; 33:356-363
61. Simpson WJ, Robbins JC, Cleary PP. Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog 1987; 3:339-50.
62. Crater DL, van de Rijn I. Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 1995; 270:18452-18458
63. Cleary P, Peterson J, Chen C, Nelson C. Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun 1991; 59:2305-2310
64. GeyerA,SchmidtKH. GeneticorganisationoftheMproteinregioninhumanisolatesofgroupCandGstreptococci: twotypesofmultigeneregulator-like(mgrC)regions.MolGenGenet2000;262: 965-976(Pubitemid30072126)
65. Derrick JP, Wigley DB. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature 1992; 359:752-754
66. Schroeder B, Boyle MD, Sheerin BR, Asbury AC, Lottenberg R. Species specificity of plasminogen activation and acquisition of surfaceassociated proteolytic activity by group C streptococci grown in plasma. Infect Immun 1999; 67:6487-6495
67. Martin NJ, Kaplan EL, Gerber MA, et al. Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol 1990; 28:1881-1886
68. Bert F, Branger C, Poutrel B, Lambert-Zechovsky N. Differentiation of human and animal strains of Streptococcus dysgalactiae by pulsedfield gel electrophoresis. FEMS Microbiol Lett. 1997; 150:107-112
69. Bert F, Branger C, Lambert-Zechovsky N. Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci. Curr Microbiol 1997; 34:226-229 (Pubitemid 27150362)
70. Biedenbach DJ, Toleman MA, Walsh TR, Jones RN. Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006; 55:119-127
71. PortnoyD,PrentisJ,RichardsGK. PenicillintoleranceofhumanisolatesofgroupCstreptococci. AntimicrobAgentsChemother1981;20:235-238(Pubitemid11015134)
72. Rolston KV, LeFrock JL. In vitro susceptibility of group G streptococci with regard to tolerance. Am J Med 1984; 77:A72, A.77.
73. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci U S A 2008; 105:19571-19578
74. Ip M, Lyon DJ, Leung T, Cheng AF. Macrolide resistance and distribution of erm and mef genes among beta-haemolytic streptococci in Hong Kong. Eur J Clin Microbiol Infect Dis 2002; 21:238-310
75. Brown DF, Hope R, Livermore DM, et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-2006. J Antimicrob Chemother 2008; 62(Suppl 2):ii75-85.
76. Amezaga MR, McKenzie H. Molecular epidemiology of macrolide resistance in β-haemolytic streptococci, of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 2006; 57:443-449
77. KatajaJ,SeppalaH,SkurnikM,SarkkinenH,HuovinenP. DifferenterythromycinresistancemechanismsingroupCandgroupGstreptococci. AntimicrobAgentsChemother1998;42:1493-1494(Pubitemid28257656)
78. Woo PC, To AP, Tse H, Lau SK, Yuen KY. Clinical and molecular epidemiology of erythromycin-resistant beta-hemolytic Lancefield group G streptococci causing bacteremia. J Clin Microbiol 2003; 41: 5188-5191 (Pubitemid 37429936)
79. Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY. Antimicrobial susceptibility patterns and macrolide resistance of β-hemolytic streptococci in Korea. Antimicrob Agents Chemother 2004; 48:2716-2718 (Pubitemid 38823449)